-
The Pistoia Alliance to Develop a Toolkit to Support Implementation of the FAIR Guiding Principles
Jul 17, 2019, 06:45 AM by Michael CroftBOSTON, MA, UNITED STATES - Jul 17, 2019 - The Pistoia Alliance, a global non-profit that works to lower barriers to innovation in life sciences R&D, today announced the launch of its FAIR Implementation project, backed by pharmaceutical companies including Roche, Astra Zeneca, and BayerFull story -
Creative Diagnostics Introduces Innovative Exosome Quantification Immunoassay Kits
Jul 17, 2019, 03:23 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 17, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announces that it has developed and optimized an innovative technology (ExoAssay) that allows specific capture of exosomes from different biological samples, including cell culture supernatants and human biological fluids (plasma, serum, urine, saliva)Full story -
BOC Sciences Improves Superparamagnetic Iron Oxide Nano/Micro Particles Preparation for Chemotherapy Research
Jul 17, 2019, 03:11 AM by Michael CroftSHIRLEY, NY, NY, UNITED STATES - Jul 17, 2019 - Having been serving the chemical industry for nearly two decades, BOC Sciences announces to continuously improve its Superparamagnetic Iron Oxide Nano/Micro Particles Preparation service, in order to help researchers engaged with chemotherapy study find a cure for some major diseases that are inflicting the human beingsFull story -
Creative Peptides Adds an Exclusive Section for Cancer Research
Jul 17, 2019, 00:14 AM by Michael CroftLONG ISLAND CITY, NY, UNITED STATES - Jul 17, 2019 - As one of the global leading peptide suppliers, Creative Peptides announced to add an exclusive section of peptides for researchers who are committed to exploring an effective solution for issues related to cancer researchFull story -
Rho Announces New Resource for Behavioral and Social Science Researchers to Prepare Research Protocols
Jul 16, 2019, 17:47 PM by Michael CroftDURHAM, NC - Jul 17, 2019 - Rho Announces New Resource for Behavioral and Social ScienceResearchers to Prepare Research ProtocolsCRO facilitated Trans-NIH committee to develop protocol template with NIDCR Research Triangle Park, NC - July 16, 2019 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that Rho's Principal Research Scientist and Program Lead Nancy Yovetich, PhD, and Project Manager Lisa Busko participated in a trans-NIH + extramural committee to develop a standardized protocol template for behavioral and social science researchersFull story -
Building A Marriage Between Medicine And Tech
Jul 12, 2019, 08:05 AM by Michael CroftFull storyBio-IT World | John-William Sidhom says the ideal scenario would be to have a system where scientific research asks the relevant questions, tech provides answers to those questions, and the physician implements those solutions for the most clinical impact.
-
Research: State of Application Security at World's 100 Largest Banks
Jul 11, 2019, 10:49 AM by Michael CroftBIRMINGHAM, GB - Jul 11, 2019 - Industry analysts and security practitioners unanimously concur that application security is a big dealFull story -
St. Jude Announces Availability Of Clinical Genome Sequencing Data In Real Time Via Cloud
Jul 11, 2019, 09:40 AM by Michael CroftFull storyBio-IT World | St. Jude Children's Research Hospital has announced the real-time availability of clinical genome sequencing data on the St. Jude Cloud.
-
Genomenon Provides Quick Answers On Fusion Genes
Jul 10, 2019, 13:55 PM by Michael CroftFull storyBio-IT World | For decades, clinicians and researchers have been fascinated by fusion genes—genomic abnormalities that form when part of the DNA from one chromosome moves to another chromosome. This helps explain the growing popularity of the Genomenon's Mastermind suite of software tools, which is more inclusive of all documented fusions.
-
Atlantic Research Group Selects Greenphire to Improve the Patient Experience for its Rare Disease and Oncology Clinical Trials
Jul 9, 2019, 13:24 PM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - Jul 9, 2019 - Greenphire, the global leader in financial software for clinical trials, announced today that it has been selected by Atlantic Research Group (ARG), a rare and neurodegenerative disease, oncology and immunology-focused contract research organization (CRO) to implement its ClinCard and ConneX solutions to improve the clinical trial experience for sites and patientsFull story -
Certara Announces the Formation of a New Practice Area Focused on Global Health
Jul 9, 2019, 09:41 AM by Michael CroftPRINCETON, NJ - Jul 9, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that it has formed a new practice area called Certara Global Health (CGH) to focus its technological expertise on helping to achieve equity in health for all people worldwideFull story -
Bellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational Trial
Jul 8, 2019, 13:29 PM by Michael CroftHOUSTON, TX - Jul 8, 2019 - Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that the primary endpoint of event free survival at 180 days in its BP-004 European registration trial for rivo-cel (rivogenlecleucel) has been achievedFull story -
PHARMASEAL Launches Second Major Release of Engility CTMS
Jul 8, 2019, 09:06 AM by Michael CroftNOTTINGHAM, UNITED KINGDOM - Jul 8, 2019 - PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, announces a second major release of its Engility CTMS platformFull story -
How Paratope Refinement Can Mitigate Antibody Polyspecificity
Jul 3, 2019, 08:15 AM by Michael CroftFull storyBio-IT World | There is often a lack of understanding in drug discovery about how polyspecificity drives antibody toxicity. This shows polyspecificity is an underappreciated phenomenon in therapeutic antibody development, but that these unwanted properties can be fully improved by paratope refinement.
-
SEKISUI XenoTech Announces Enhanced Synergy in ADME Testing Services
Jul 2, 2019, 14:12 PM by Michael CroftKANSAS CITY, KS, UNITED STATES - Jul 2, 2019 - SEKISUI XenoTech is collaborating with the Drug Development Solutions Center to offer a full suite of nonclinical testing services specializing in the evaluation of Absorption, Distribution, Metabolism, and Excretion (ADME) in potential new drugsFull story -
MELLODDY Using Federated Learning To Improve Drug Development
Jul 2, 2019, 14:00 PM by Michael CroftFull storyBio-IT World | A 17-partner consortium in Europe is seeking to confirm the utility of a machine learning platform for better predicting promising compounds for drug development. The three-year initiative, which launched in June, represents the first large-scale deployment of blockchain technology to extract insights from multiple preclinical datasets without having to first pool the data.
-
MGI Responds to Illumina Lawsuits with Confidence in the Strength of its Patent Portfolio
Jul 2, 2019, 13:32 PM by Michael CroftSAN JOSE, CA - Jul 2, 2019 - MGI Responds to Illumina Lawsuits with Confidence in the Strength of its Patent PortfolioCalls for Fair Competition in the Gene Sequencing Market MGI, a subsidiary of BGI Group, expressed confidence in its core patent portfolio in the field of gene sequencing and vowed to fully support the industry to achieve higher quality, more cost-effective sequencingFull story -
Antibodies.com Raises £400,000 Pre-Seed Round to Help Researchers Discover More For Less
Jul 2, 2019, 05:27 AM by Michael Croft, CAMBRIDGE, UNITED KINGDOM - Jul 2, 2019 - Antibodies.com, a digital marketplace that enables life scientists to purchase critical research reagents at cost-effective prices from the primary manufacturers, today announced that is has raised £400,000 in pre-seed financingFull story -
LabTwin, AbCellera, X4, And More: News From June 2019
Jul 1, 2019, 10:05 AM by Michael CroftFull storyBio-IT World | June featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including LabTwin, AbCellera, X4, and more.
-
Creative Diagnostics Launches Viral Antigens for Science Community
Jul 1, 2019, 03:31 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 1, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announced that it has launched a series of viral antigens for biological research use, including Adenovirus, CMV, Coronavirus, Coxsackievirus, Dengue Virus, EBV, EV71, Ebola Virus, HAV, HBV and so onFull story